beta amyloid protein | What is beta amyloid protein|Papers on beta amyloid protein|Research on beta amyloid protein | Publications on beta amyloid

1.

Isolation of synaptic terminals from Alzheimer's disease cortex.

Sokolow S, Henkins KM, Williams IA, Vinters HV, Schmid I, Cole GM, Gylys KH.

Cytometry A. 2011 Dec 28. doi: 10.1002/cyto.a.22009. [Epub ahead of print]

PMID:

22213704

[PubMed - as supplied by publisher]

Related citations

2.

Immunodistribution of amyloid beta protein (Aβ) and advanced glycation end-product receptors (RAGE) in choroid plexus and ependyma of resuscitated patients.

Maślińska D, Laure-Kamionowska M, Taraszewska A, Deręgowski K, Maśliński S.

Folia Neuropathol. 2011;49(4):295-300.

PMID:

22212919

[PubMed - in process]

Related citations

3.

Amine oxidase activity of β-amyloid precursor protein modulates systemic and local catecholamine levels.

Duce JA, Ayton S, Miller AA, Tsatsanis A, Lam LQ, Leone L, Corbin JE, Butzkueven H, Kilpatrick TJ, Rogers JT, Barnham KJ, Finkelstein DI, Bush AI.

Mol Psychiatry. 2012 Jan 3. doi: 10.1038/mp.2011.168. [Epub ahead of print]

PMID:

22212595

[PubMed - as supplied by publisher]

Related citations

4.

Mapping out the multi-stage fibrillation of glucagon.

Ghodke S, Nielsen SB, Christiansen G, Hjuler HA, Flink J, Otzen D.

FEBS J. 2011 Dec 23. doi: 10.1111/j.1742-4658.2011.08465.x. [Epub ahead of print]

PMID:

22212535

[PubMed - as supplied by publisher]

Related citations

5.

The early events of Alzheimer's disease pathology: from mitochondrial dysfunction to BDNF axonal transport deficits.

Ye X, Tai W, Zhang D.

Neurobiol Aging. 2011 Dec 31. [Epub ahead of print]

PMID:

22212405

[PubMed - as supplied by publisher]

Related citations

6.

Control of BACE1 degradation and APP processing by ubiquitin carboxyl-terminal hydrolase L1.

Zhang M, Deng Y, Luo Y, Zhang S, Zou H, Cai F, Wada K, Song W.

J Neurochem. 2011 Dec 30. doi: 10.1111/j.1471-4159.2011.07644.x. [Epub ahead of print]

PMID:

22212137

[PubMed - as supplied by publisher]

Related citations

7.

Obovatol improves cognitive functions in animal models for Alzheimer's disease.

Choi DY, Lee JW, Lin G, Lee YJ, Ban JO, Lee YH, Choi IS, Han SB, Jung JK, Lee WS, Lee SH, Kwon BM, Oh KW, Hong JT.

J Neurochem. 2011 Dec 30. doi: 10.1111/j.1471-4159.2011.07642.x. [Epub ahead of print]

PMID:

22212065

[PubMed - as supplied by publisher]

Related citations

8.

Resveratrol, a neuroprotective supplement for Alzheimer's disease.

Li F, Gong Q, Dong H, Shi J.

Curr Pharm Des. 2012 Jan 1. [Epub ahead of print]

PMID:

22211686

[PubMed - as supplied by publisher]

Related citations

9.

The profile of β-amyloid precursor protein expression of rats induced by aluminum.

Li XB, Zhang ZY, Yin LH, Schluesener HJ.

Environ Toxicol Pharmacol. 2011 Dec 10;33(2):135-140. [Epub ahead of print]

PMID:

22209725

[PubMed - as supplied by publisher]

Related citations

10.

Trans fatty acids enhance amyloidogenic processing of the Alzheimer amyloid precursor protein (APP).

Grimm MO, Rothhaar TL, Grösgen S, Burg VK, Hundsdörfer B, Haupenthal VJ, Friess P, Kins S, Grimm HS, Hartmann T.

J Nutr Biochem. 2011 Dec 29. [Epub ahead of print]

PMID:

22209004

[PubMed - as supplied by publisher]

Related citations

11.

Altered CSF Orexin and α-Synuclein Levels in Dementia Patients.

Wennström M, Londos E, Minthon L, Nielsen HM.

J Alzheimers Dis. 2011 Dec 29. [Epub ahead of print]

PMID:

22207004

[PubMed - as supplied by publisher]

Related citations

12.

Calpastatin modulates APP processing in the brains of β-amyloid depositing but not wild-type mice.

Morales-Corraliza J, Berger JD, Mazzella MJ, Veeranna, Neubert TA, Ghiso J, Rao MV, Staufenbiel M, Nixon RA, Mathews PM.

Neurobiol Aging. 2011 Dec 27. [Epub ahead of print]

PMID:

22206846

[PubMed - as supplied by publisher]

Related citations

13.

The Nogo receptor 2 is a novel substrate of Fbs1.

Kern F, Sarg B, Stasyk T, Hess D, Lindner H.

Biochem Biophys Res Commun. 2011 Dec 20. [Epub ahead of print]

PMID:

22206664

[PubMed - as supplied by publisher]

Related citations

14.

Phosphorus Dendrimers Affect Alzheimer's (Aβ1-28) Peptide and MAP-Tau Protein Aggregation.

Wasiak T, Ionov M, Nieznanski K, Nieznanska H, Klementieva O, Granell M, Cladera J, Majoral JP, Caminade PA, Klajnert B.

Mol Pharm. 2011 Dec 29. [Epub ahead of print]

PMID:

22206488

[PubMed - as supplied by publisher]

Related citations

15.

Brain Serum Amyloid P Levels are Reduced in Individuals that Lack Dementia While Having Alzheimer's Disease Neuropathology.

Crawford JR, Bjorklund NL, Taglialatela G, Gomer RH.

Neurochem Res. 2011 Dec 29. [Epub ahead of print]

PMID:

22205573

[PubMed - as supplied by publisher]

Related citations

16.

Statins in Unconventional Secretion of Insulin-Degrading Enzyme and Degradation of the Amyloid-β Peptide.

Glebov K, Walter J.

Neurodegener Dis. 2011 Dec 23. [Epub ahead of print]

PMID:

22205103

[PubMed - as supplied by publisher]

Related citations

17.

p53, a Pivotal Effector of a Functional Cross-Talk Linking Presenilins and Pen-2.

Checler F, Dunys J.

Neurodegener Dis. 2011 Dec 23. [Epub ahead of print]

PMID:

22205087

[PubMed - as supplied by publisher]

Related citations

18.

Fibrillar Amyloid-β1-42 Modifies Actin Organization Affecting the Cofilin Phosphorylation State: A Role for Rac1/cdc42 Effector Proteins and the Slingshot Phosphatase.

Mendoza-Naranjo A, Contreras-Vallejos E, Henriquez DR, Otth C, Bamburg JR, Maccioni RB, Gonzalez-Billault C.

J Alzheimers Dis. 2011 Dec 27. [Epub ahead of print]

PMID:

22204905

[PubMed - as supplied by publisher]

Related citations

19.

The Alzheimer's beta-secretase enzyme BACE1 is required for accurate axon guidance of olfactory sensory neurons and normal glomerulus formation in the olfactory bulb.

Rajapaksha TW, Eimer WA, Bozza TC, Vassar R.

Mol Neurodegener. 2011 Dec 28;6(1):88. [Epub ahead of print]

PMID:

22204380

[PubMed - as supplied by publisher]

Free Article

Related citations

20.

Inflammatory markers in hyperlipidemia: from experimental models to clinical practice.

Siasos G, Tousoulis D, Oikonomou E, Zaromitidou M, Stefanadis C, Papavassiliou AG.

Curr Pharm Des. 2011 Dec;17(37):4132-46.